Tagged with Translational Research

Bana Jabri – Director, Institut Imagine

France Bana Jabri – Director, Institut Imagine

France Professor Bana Jabri, Director of the Institut Imagine, brings a transatlantic perspective to advancing genetic medicine. After 25 years in the US, she now leads efforts in France to harness genomic technologies, foster interdisciplinary collaboration, and modernise academic–industry partnerships. Her vision calls for strategic investment, institutional autonomy, and greater risk…

Andrea Alimonti – Professor at the Department of Health Sciences and Technology, Institute of Oncology Research (IOR)

Switzerland Andrea Alimonti – Professor at the Department of Health Sciences and Technology, Institute of Oncology Research (IOR)

Switzerland Prof. Andrea Alimonti, Director of the Institute of Oncology Research in Bellinzona, a leading Swiss centre focused on translational cancer research, shares his international journey from Rome to New York , Boston, and now Ticino, where he leads a growing, high-impact research institute. Under his leadership, IOR is expanding with…

Interview: Grace Zhou – Dean, Shenzhen International Institute for Biomedical Research (SIIBR), China

China Interview: Grace Zhou – Dean, Shenzhen International Institute for Biomedical Research (SIIBR), China

China Dr. Grace Zhou, dean of SIIBR, discusses the Institute’s priorities, the benefits of being located in Shenzhen and the city’s potential as a global innovation hub. Zhou also outlines the major recent developments for her company, ImmVira. To begin with, Grace, our readers would be extremely interested in hearing about…

Keith Thompson – CEO, Cell and Gene Therapy Catapult, UK

UK Keith Thompson – CEO, Cell and Gene Therapy Catapult, UK

UK Keith Thompson, CEO of the Cell & Gene Therapy Catapult, one of a number of Catapult institutions in the UK designed to help commercialize innovative research, discusses strategy, funding, international collaboration and Brexit. Most likely, the UK is the best environment for putting forward trials that are properly…

Interview: Tony Jones – CEO, One Nucleus, UK

UK Interview: Tony Jones – CEO, One Nucleus, UK

UK Tony Jones, CEO of One Nucleus, a life sciences membership organization centered on the Greater London-Cambridge-East of England corridor, discusses the role of SMEs within the UK’s healthcare ecosystem, translational research, and how the association’s members will navigate the post-Brexit landscape in the UK. One Nucleus, which was established in…

Interview: Alexander Eggermont – Director-General, Gustave Roussy Institute, France

Pharma Interview: Alexander Eggermont – Director-General, Gustave Roussy Institute, France

Pharma The Director-General of the Gustave Roussy Institute, a top cancer institute in Europe, talks about the revamping of their clinical research infrastructure to adapt to the rising new field of translational research and his ambitious plans for the next five years, in particular, his vision for Cancer Core Europe, positioned…

Interview: Marie Lang, Director and Francis Willig, in charge of the Industrial Sector, CNCR, Le Comité National de Coordination de la Recherche (National Committee for Research Co-ordination), France

pharma Interview: Marie Lang, Director and Francis Willig, in charge of the Industrial Sector, CNCR, Le Comité National de Coordination de la Recherche (National Committee for Research Co-ordination), France

pharma The Director of the CNCR and the person in charge of the industrial sector, talk about the fragmented nature of French clinical research funding, why when it comes to boosting France’s attractiveness as a clinical research destination, funding is the number one issue for hospitals and reveals how the number…